NMC Health (LON:NMC)‘s stock had its “buy” rating reissued by stock analysts at Berenberg Bank in a report released on Wednesday. They currently have a GBX 4,000 ($53.84) target price on the stock. Berenberg Bank’s price objective would suggest a potential upside of 45.99% from the stock’s current price.
Separately, Jefferies Group reissued a “hold” rating and issued a GBX 2,810 ($37.82) price objective on shares of NMC Health in a report on Wednesday, November 15th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the stock. NMC Health presently has a consensus rating of “Buy” and an average target price of GBX 2,522 ($33.94).
Shares of NMC Health (LON:NMC) opened at GBX 2,740 ($36.88) on Wednesday. NMC Health has a 1 year low of GBX 1,406 ($18.92) and a 1 year high of GBX 3,211 ($43.22).
About NMC Health
NMC Health plc is a private healthcare services provider in the United Arab Emirates. The Company operates through two segments: healthcare and distribution & services. The healthcare segment is engaged in providing professional medical services, comprising diagnostic services, in and outpatient clinics, provision of all types of research and medical services in the field of gynecology, obstetrics and human reproduction and retailing of pharmaceutical goods.
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.